Staniloaie Daniel, Budin Constantin, Vasile Danut, Iancu George, Ilco Alexandru, Voiculescu Daniel Iulian, Trandafir Alexandra Florina, Ammar Tarek, Suliman Emel, Suliman Emine, Dragoş Dorin, Tanasescu Maria-Daniela
Department of General Surgery, Faculty of Medicine, 'Carol Davila' University of Medicine and Pharmacy, 020021 Bucharest, Romania.
1st Department of General Surgery, Bucharest Emergency University Hospital, 050098 Bucharest, Romania.
Exp Ther Med. 2022 Jan;23(1):72. doi: 10.3892/etm.2021.10995. Epub 2021 Nov 24.
The identification of sentinel lymph nodes is a valuable oncological method, which aims at mapping lymphatic drainage and has the advantage of correctly staging the disease and assessing prognosis. Lymph node invasion is an important prognostic feature. In colorectal cancer, lymphadenectomy is not influenced by the positive or negative status of the sentinel lymph node. The identification of lymph nodes with possible invasion by staining the primary tumor with methylene blue can lead to improved staging and management. In other words, the consequent administration of neoadjuvant therapy (chemotherapy) to the appropriate patients may result in lower recurrence rates. Thus, the aim of the present study was to use methylene blue to identify the sentinel node/nodes in colorectal cancer and to determine whether the dye-capturing nodes were invaded by the tumor. This is a non-randomized prospective study, in which 26 patients with colon cancer with surgical indication were enrolled. Two types of methods were utilized: (16 patients) and (10 patients). The identification rate was 75% for the technique and 60% for the technique, resulting in a 69.26% overall identification rate. Of 18 patients with sentinel lymph nodes identified using dye, routine histological examination detected metastases in 6 (33.33%) of these patients. In conclusion, further research should be conducted into how the clinical application of sentinel node detection can be employed in colorectal cancer.
前哨淋巴结的识别是一种有价值的肿瘤学方法,其目的是绘制淋巴引流图,具有正确分期疾病和评估预后的优势。淋巴结侵犯是一个重要的预后特征。在结直肠癌中,淋巴结清扫不受前哨淋巴结状态阳性或阴性的影响。用亚甲蓝对原发肿瘤进行染色来识别可能受侵犯的淋巴结,可改善分期和治疗管理。换句话说,随后对合适的患者给予新辅助治疗(化疗)可能会降低复发率。因此,本研究的目的是使用亚甲蓝来识别结直肠癌中的前哨淋巴结,并确定摄取染料的淋巴结是否被肿瘤侵犯。这是一项非随机前瞻性研究,纳入了26例有手术指征的结肠癌患者。采用了两种方法:(16例患者)和(10例患者)。技术的识别率为75%,技术的识别率为60%,总体识别率为69.26%。在18例通过染料识别出前哨淋巴结的患者中,常规组织学检查在其中6例(33.33%)患者中检测到转移。总之,应进一步研究前哨淋巴结检测的临床应用如何应用于结直肠癌。